Bioequivalence of Cefamandole Nafate I.V. (Mandol and Mancef) of Human Volunteers

Cefamandole nafate 함유 주사제의 지원자에 대한 생물학적 동등성 시험

  • Kwon, Kwang-Il (College of Pharmacy, Chung Nam National University) ;
  • Lee, Hye-Suk (Korea Research Institute of Chemical Technology) ;
  • Zee, Ok-Pyo (Korea Research Institute of Chemical Technology)
  • 권광일 (충남대학교 약학대학) ;
  • 이혜숙 (한국화학연구소 의약활성연구실) ;
  • 지옥표 (한국화학연구소 의약활성연구실)
  • Published : 1990.10.28

Abstract

The bioequivalence of Mandol and Mancef (cefamondole nafate injection preparation) was investigated for 8 healthy human volunteers. Cefamandole nafate hydrolysis to cefamandole base in the blood and shows antibacterial activity. As the rate of the hydrolysis can be varied according to the buffer used in the preparation, the bioequivalence of cefamandole nafate I.V. was studied. A new HPLC method, the column switching technique, was developed and used for the simultaneous determination of cefamandole and cefamandole nafate in the plasma and in the urine. There were no statistically significant difference in between Mandol and Mancef for the parameters of AUC and Cp 0.25 hr even through the power of the test was not enough.

Keywords